Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8734834 | 0.82 | SIGMAR1 (0.51) | SIGMAR1 | |
| SCHEMBL3921394 | 0.76 | — | — | |
| SCHEMBL18912886 | 0.74 | SIGMAR1 (0.41) | SIGMAR1 | |
| SCHEMBL20723859 | 0.74 | SIGMAR1 (0.41) | SIGMAR1 | |
| SCHEMBL27792348 | 0.73 | — | — | |
| SCHEMBL8736360 | 0.72 | SIGMAR1 (0.56) | SIGMAR1 | |
| SCHEMBL22656902 | 0.67 | SIGMAR1 (0.48) | SIGMAR1 | |
| SCHEMBL11111485 | 0.67 | SIGMAR1 (0.32) | SIGMAR1 | |
| SCHEMBL8406252 | 0.67 | SIGMAR1 (0.48) | SIGMAR1 | |
| SCHEMBL4095133 | 0.67 | DPP4 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160304445-A1 | N,N-BIS(2-AMINOALKYL)-1,2-ALKYL DIAMINE DERIVATIVES | BASF SE (DE) | 2016-10-20 | — | — | US | disclosed |
| US-20160304445-A1 | N,N-BIS(2-AMINOALKYL)-1,2-ALKYL DIAMINE DERIVATIVES | BASF SE (DE) | 2016-10-20 | — | — | US | disclosed |
| WO-2015086293-A1 | N,N-BIS(2-AMINOALKYL)-1,2-ALKYL DIAMINE DERIVATIVES | BASF SE (DE) | 2015-06-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160304445-A1 | N,N-BIS(2-AMINOALKYL)-1,2-ALKYL DIAMINE DERIVATIVES | PARN, NIT2, NAT1 | SIGMAR1 1105/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.